Protein shows potential to accelerate cancer therapy research and application

October 25, 2021, 3:05PMNuclear News
LLNL and Penn State researchers developed a new approach to study and purify medical isotopes, including actinium. (Image: Thomas Reason/LLNL)

Scientists at Lawrence Livermore National Laboratory and Pennsylvania State University have demonstrated that a natural protein found bonded to rare earth elements can be recovered and used as a tool to purify and effectively manage radioactive metals that show promise for cancer therapy and the detection of illicit nuclear activities.

To continue reading, log in or create a free account!

Related Articles

Taking aim at disease

Radioisotopes target cancer, improve imaging, and have myriad other medical uses

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...

NNSA publishes LLNL’s final EIS

November 7, 2023, 12:04PMNuclear News

The Department of Energy’s National Nuclear Security Administration has published a notice of a final sitewide environmental impact statement for continued operation of Lawrence Livermore...